Correlation Between Sangui Biotech and Regencell Bioscience

Can any of the company-specific risk be diversified away by investing in both Sangui Biotech and Regencell Bioscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sangui Biotech and Regencell Bioscience into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sangui Biotech International and Regencell Bioscience Holdings, you can compare the effects of market volatilities on Sangui Biotech and Regencell Bioscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sangui Biotech with a short position of Regencell Bioscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sangui Biotech and Regencell Bioscience.

Diversification Opportunities for Sangui Biotech and Regencell Bioscience

-0.08

Correlation Coefficient

Sangui Biotech  Regencell Bioscience

Good diversification

The 3 months correlation between Sangui and Regencell is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Sangui Biotech International and Regencell Bioscience Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regencell Bioscience and Sangui Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sangui Biotech International are associated (or correlated) with Regencell Bioscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regencell Bioscience has no effect on the direction of Sangui Biotech i.e., Sangui Biotech and Regencell Bioscience go up and down completely randomly.

Pair Corralation between Sangui Biotech and Regencell Bioscience

If you would invest  482.00  in Regencell Bioscience Holdings on December 29, 2024 and sell it today you would earn a total of  3,005  from holding Regencell Bioscience Holdings or generate 623.44% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	95.31%
Values	Daily Returns

Sangui Biotech International  vs.  Regencell Bioscience Holdings

Sangui Biotech Inter

Risk-Adjusted Performance

Very Weak

Over the last 90 days Sangui Biotech International has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong fundamental drivers, Sangui Biotech is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Regencell Bioscience

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Regencell Bioscience Holdings are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile technical and fundamental indicators, Regencell Bioscience exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Sangui Biotech and Regencell Bioscience

The main advantage of trading using opposite Sangui Biotech and Regencell Bioscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sangui Biotech position performs unexpectedly, Regencell Bioscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regencell Bioscience will offset losses from the drop in Regencell Bioscience's long position.

The idea behind Sangui Biotech International and Regencell Bioscience Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .